Welcome to LookChem.com Sign In|Join Free

CAS

  • or

952182-78-4

Post Buying Request

952182-78-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

952182-78-4 Usage

Properties

Different sources of media describe the Properties of 952182-78-4 differently. You can refer to the following data:
1. Organic thioamide, contains a trifluoromethylphenyl group
2. Thioamide derivative, contains an aminothioxoethyl group

Application

Different sources of media describe the Application of 952182-78-4 differently. You can refer to the following data:
1. Used in the synthesis of pharmaceuticals and agrochemicals

2. Used in the production of pharmaceuticals and agrochemicals

Check Digit Verification of cas no

The CAS Registry Mumber 952182-78-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,2,1,8 and 2 respectively; the second part has 2 digits, 7 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 952182-78:
(8*9)+(7*5)+(6*2)+(5*1)+(4*8)+(3*2)+(2*7)+(1*8)=184
184 % 10 = 4
So 952182-78-4 is a valid CAS Registry Number.

952182-78-4Relevant articles and documents

Design, synthesis, and pharmacological evaluation of 4-azolyl-benzamide derivatives as novel GPR52 agonists

Tokumaru, Kazuyuki,Ito, Yoshiteru,Nomura, Izumi,Nakahata, Takashi,Shimizu, Yuji,Kurimoto, Emi,Aoyama, Kazunobu,Aso, Kazuyoshi

, p. 3098 - 3115 (2017/05/24)

G protein-coupled receptor 52 (GPR52) agonists are expected to improve the symptoms of psychiatric disorders. During exploration for a novel class of GPR52 agonists with good pharmacokinetic profiles, we synthesized 4-(3-(3-fluoro-5-(trifluoromethyl)benzyl)-5-methyl-1H-1,2,4-triazol-1-yl)-2-methylbenzamide (4u; half maximal effective concentration (EC50)?=?75?nM, maximal response (Emax)?=?122%) starting from a high-throughput screening hit 3 (EC50?=?470?nM, Emax?=?56%). The structural features of a reported GPR52 agonist were applied to 3, led to design 4-azolylbenzamides as novel GPR52 agonists. A structure–activity relationship study of 4-azolylbenzamide resulted in the design of the 1,2,4-triazole derivative 4u, which demonstrated excellent bioavailability in rats (F?=?53.8%). Oral administration of 4u (10?mg/kg) significantly suppressed methamphetamine-induced hyperlocomotion in mice. Thus, 4u is a promising lead compound for drug discovery research of GPR52 agonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 952182-78-4